News Flaggemelding Staff August 22, 2025 Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding ASA. Iframe sync Post navigation Previous: Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment ConferenceNext: Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP) More Stories News The UA Sprinkler Fitters Local 669 JATC – Notice of Privacy Incident Staff February 7, 2026 Diagnostics Healthcare News Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro Staff February 6, 2026 Diagnostics News GEARWRENCH Continues to Redefine Automotive Diagnostics with Powerful New Tools Staff February 6, 2026
